Process safety
During the production process, microbiological tests are performed, including serology, complete blood count, and quality controls.
PRP 101
What is platelet-rich plasma?
Platelet-rich plasma (PRP) is obtained by concentrating platelets from a small sample of a patient's own blood.
The resulting plasma contains growth factors and signaling proteins that support controlled tissue regeneration when used in appropriate clinical contexts.
From extraction to administration
Each stage is designed to preserve platelet quality and consistency for predictable outcomes.
Extraction1
Blood is collected in a bag using a closed system. A single blood draw provides multiple applications with 12-month shelf life.
1
Concentration2
High-efficiency double centrifugation achieves a platelet concentration five times over the baseline value.
2
Activation3
According to the indication, platelets are activated just before use to release their growth factors.
3
Administration4
The concentrated plasma is delivered by trained professionals in accordance with clinic protocols and regulatory guidance.
4
Our production process
Benefits for the patient
Medical report and platelet count. A single blood draw provides the entire treatment.
Safety for the hospital
Closed-system process. Sterility testing. Traceability. Compliance with current Spanish and European safety standards.
Evidence, safety, and transparency
We partner with scientific advisors to review the latest publications, regulatory updates, and best practices so teams can make informed decisions about PRP integration.
ISO 13485 ready